SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-025014
Filing Date
2021-05-06
Accepted
2021-05-06 16:23:02
Documents
64
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q harp-10q_20210331.htm 10-Q 2475671
2 EX-10.1 harp-ex101_60.htm EX-10.1 25580
3 EX-31.1 harp-ex311_6.htm EX-31.1 17646
4 EX-31.2 harp-ex312_7.htm EX-31.2 17603
5 EX-32.1 harp-ex321_8.htm EX-32.1 10724
  Complete submission text file 0001564590-21-025014.txt   8240559

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT harp-20210331.xml EX-101.INS 1905799
7 XBRL TAXONOMY EXTENSION SCHEMA harp-20210331.xsd EX-101.SCH 50769
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE harp-20210331_cal.xml EX-101.CAL 44896
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE harp-20210331_def.xml EX-101.DEF 164613
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE harp-20210331_lab.xml EX-101.LAB 381511
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE harp-20210331_pre.xml EX-101.PRE 291672
Mailing Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-443-7400
Harpoon Therapeutics, Inc. (Filer) CIK: 0001708493 (see all company filings)

IRS No.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38800 | Film No.: 21898163
SIC: 2836 Biological Products, (No Diagnostic Substances)